Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

The eye as a window to the brain, extending lifelong brain health

Nocturne

Nocturne specializes in products and services that allow diagnosing neurologic disorders through imaging of the eye. Nocturne’s proprietary technology (patent pending) analyses 3D images of the retina, which are obtained by optical coherence tomography (OCT). OCT is a noninvasive imaging technology routinely used in ophthalmology. Standard OCT...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

The Fast Periodic Visual Stimulation: a sensitive and objective approach to identify early cognitive markers of AD

ElectroMAD

Demographic analyses predict that one third of the 10 millions Belgian population in 2050 will be above 60 years of age. Since aging is the major risk factor for Alzheimer’s disease (AD), this increase in the proportion of seniors is closely linked to the increased prevalence of AD. With the advent of promising symptomatic treatment, it is critical...

Funding Programme
Start Date
End Date
Total Funding
€ 160 800
European Countries Involved

The neuroenergetics of memory consolidation – hybrid PET/MR imaging of the default mode network

SUGARCODING

Since its discovery more than a decade ago, the most studied network in the human brain remains a paradox. The default mode network (DMN) is most active during the resting state and deactivates once subjects engage in goal directed behavior. Although reported in hundreds of studies using functional magnetic resonance imaging (fMRI), the function of...

Funding Programme
Start Date
End Date
Total Funding
€ 1 499 404
European Countries Involved

The Next-Generation of Small, Cost-Effective and Mobile Brain Scanner for an Early Detection of Alzheimer’s Disease

BPET

Alzheimer’s (AD) is a global epidemic with 50 M people suffering it and 76 M expected by 2030 (related costs near $1 Tri in 2018). To diminish its burden, an early detection is crucial, specially when modifying treatments become available. The most accurate method to measure AD hallmarks is positron emission tomography (PET), but current PET...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

The role of immune cells in Alzheimer's disease

IMMUNOALZHEIMER

Alzheimer’s disease is the most common form of dementia affecting more than 35 million people worldwide and its prevalence is projected to nearly double every 20 years with tremendous social and economical impact on the society. There is no cure for Alzheimer's disease and current drugs only temporarily improve disease symptoms. Alzheimer's...

Funding Programme
Start Date
End Date
Total Funding
€ 2 500 000
European Countries Involved

The Role of Neuroinflammation in Alzheimer’s Disease

INFLAMM-ALZ

Alzheimer’s disease (AD) is a major public health problem with substantial economical and social impacts worldwide. Despite intense research, the pathological mechanisms of AD are still unclear. Under homeostasis, a delicate balance is struck between disposal of pathogenic proteins by the brain’s immune cells, microglia, and the inflammation...

Funding Programme
Start Date
End Date
Total Funding
€ 173 857
European Countries Involved

The Unfolded Protein Response in Neurodegeneration

UPR NEURO

This proposal aims to increase our understanding of the role of translational failure in human neurodegenerative diseases. We recently discovered the mechanism by which protein misfolding leads to neurodegeneration in prion disease. The pathway involved is a generic cellular pathway, a branch of the unfolded protein response (UPR) that controls...

Funding Programme
Start Date
End Date
Total Funding
€ 1 979 286
European Countries Involved

The use of computational techniques to Improve compliance to reminders within smart environments

REMIND

The aim of this Project is to create an International and Intersectoral network to facilitate the exchange of staff to progress developments in reminding technologies for persons with dementia which can be deployed in smart environments. The focus will be on developing staff and partner skills in the areas of user centered design and behavioral...

Funding Programme
Start Date
End Date
Total Funding
€ 1 084 500
European Countries Involved

Theoretical prediction of spectral biomarkers for Alzheimer's disease enabled by highly efficient and adaptable mutli-level response methods

FreezeAlz

Luminescent conjugated oligothiophenes are highly promising candidates for biomarkers for amyloid misfolds and thereby for early-stage detection of neurodegenerative diseases such as Alzheimer’s and Parkinson's disease. The elucidation of the microscopic mechanism and design principles behind these biomarkers requires theoretical assistance...

Funding Programme
Start Date
End Date
Total Funding
€ 173 857
European Countries Involved

Tracking and predicting neurodegeneration spreading across the brain connectome

NeuroTRACK

Current knowledge of neurodegenerative diseases is limited by poor understanding of how they progress through the central nervous system (CNS). It has recently been hypothesized that clinical progression in these conditions involves the systematic spreading of protein misfolding along neuronal pathways. Protein aggregates would trigger misfolding...

Funding Programme
Start Date
End Date
Total Funding
€ 1 496 994
European Countries Involved

Tracking the Effects of Amyloid and Tau Pathology on Brain Systems and Cognition in Early Alzheimer’s Disease

TRACE-AD

Alzheimer’s disease (AD) is a tremendous burden and there are still no therapies available. Most clinical trials have focused on the late disease stages where neuronal damage is already severe and irreversible. To intervene in earlier stages, it is essential to understand how AD pathology affects brain systems early in the disease. Beyond that, we...

Funding Programme
Start Date
End Date
Total Funding
€ 191 852
European Countries Involved

Training Network on Automatic Processing of PAthological Speech

TAPAS

There are an increasing number of people across Europe with debilitating speech pathologies (e.g., due to stroke, Parkinson's, etc). These groups face communication problems that can lead to social exclusion. They are now being further marginalised by a new wave of speech technology that is increasingly woven into everyday life but which is not...

Funding Programme
Start Date
End Date
Total Funding
€ 3 856 029
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).